Cigna Beats Q1 Revenue Estimates, Raises Full-Year Guidance
CI sits 21% above its 52-week low of $239.51.
Summary
Cigna Group reported strong first-quarter results, with adjusted revenue of $68.52 billion significantly surpassing analyst estimates of $66.37 billion. The company also raised its full-year 2026 outlook for adjusted income from operations per share to at least $30.35, driven by robust performance in its Evernorth Health Services and Cigna Healthcare segments. This positive earnings beat and upward revision of guidance are highly material for the company, indicating strong operational execution and improved profitability expectations. The news suggests continued momentum from its strategic optimization program, as highlighted in its recent annual report. Traders will be watching for sustained growth in specialty pharmacy and continued margin improvement across its healthcare divisions.
At the time of this announcement, CI was trading at $291.00 on NYSE in the Life Sciences sector, with a market capitalization of approximately $77.1B. The 52-week trading range was $239.51 to $350.00. This news item was assessed with positive market sentiment and an importance score of 9 out of 10. Source: Reuters.